Analyst firms · BofA Securities · TYRA
BofA Securities TYRA price target and rating history
Tyra Biosciences Inc. (TYRA) · Health Care
BofA Securities rates Tyra Biosciences Inc. (TYRA) Buy with a $31 price target, as of its latest action on Oct 18, 2024. It has published 3 rating actions on TYRA since October 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a TYRA price target in the last 12 months, the median target is $54.
- Current rating
- Buy
- Price target
- $31
- Median target, all firms
- $54
- Actions on TYRA
- 3
BofA Securities price target on TYRA
Every BofA Securities rating on TYRA
- Oct 18, 2024
- Dec 15, 2023
- Oct 11, 2021
How other firms rate TYRA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wolfe Research | Peer Perform | May 19, 2026 | |
| Guggenheim | Buy | $54 | Apr 15, 2026 |
| Canaccord Genuity | Buy | $50 | Apr 6, 2026 |
| Cantor Fitzgerald | Overweight | Feb 24, 2026 | |
| William Blair | Outperform | Feb 10, 2026 | |
| Barclays | Overweight | $59 | Jan 28, 2026 |
Questions about BofA Securities and TYRA
- What is BofA Securities's price target for TYRA?
- BofA Securities's latest stated price target for Tyra Biosciences Inc. (TYRA) is $31, from its action on Oct 18, 2024.
- What is BofA Securities's rating on TYRA?
- BofA Securities rates TYRA Buy, a bullish rating, as of Oct 18, 2024.
- When did BofA Securities last change its view on TYRA?
- On Oct 18, 2024, BofA Securities upgrades to Buy from Neutral, price target $22 to $31.
- How does BofA Securities's TYRA target compare with other analysts?
- Across 3 firms with a TYRA price target in the last 12 months, the median target is $54.
More TYRA rating histories
All BofA Securities ratingsTYRA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.